Case Management

Study: Birth control may reduce risk of MS

Case Management Weekly, September 14, 2005

Want to receive articles like this one in your inbox? Subscribe to Case Management Weekly!

Women taking oral contraceptives for more than three years may be less likely to develop multiple sclerosis (MS). According to a study published in the September issue of the Archives of Neurology, women who use oral contraceptives are 40% less likely to develop MS.

Findings suggest that estrogen - the hormone found in birth control - interrupts/changes the disease's path, lessening the risk for MS development. Pregnancy was also cited as a possible period for decreased risk of MS; this is due to the intense hormonal changes women undergo during such times. Conversely, researchers reported the postpartum period as being most risky for disease onset.

Source: The Journal of the American Medical Association



Want to receive articles like this one in your inbox? Subscribe to Case Management Weekly!

    Case Management Weekly
  • Case Management Weekly

    Case Management Weekly is a free e-mail newsletter that offers news, resources, and Q&As to help case managers from all...

  • Case Management Monthly

    This newsletter offers case studies, best practices, and how-to analysis to help case managers move patients through the...

Most Popular

Related Articles